Skip to main content Presents the DayOne Acceleration Program Supported by Fondation Botnar

| News Presents the DayOne Acceleration Program Supported by Fondation Botnar


Seeking brilliant project ideas that, combined with digital technologies, healthcare expertise and entrepreneurial spirit, will help solve the health challenges and unmet needs of young people. Selected projects will receive up to 70,000 CHF in non-dilutive funding.

DayOne, the swiss innovation hub for precision medicine and digital health run by, is launching an acceleration program supported by Fondation Botnar. Applications are now open to project ideas improving the wellbeing and health of children and adolescents worldwide.

The acceleration program will include a tailor-made mentoring program, access to DayOne industry experts and collaborative workspace at the DayOne Lab. Selected projects will receive up to 70,000 CHF in non-dilutive funding. We are looking for brilliant ideas that, combined with digital technologies, healthcare expertise and entrepreneurial spirit, will help solve the health challenges and unmet needs of young people.

The program welcomes healthcare innovators, start-ups and entrepreneurs as well as intrapreneurs willing to accelerate their project outside of their corporate environment.

We at DayOne believe that healthcare is moving from the hospital to the living room and changing from a sick repair system to a health system. Therefore, Fondation Botnar through the DayOne Acceleration program is reaching out to healthcare innovators who are passionate about developing new approaches to improve the wellbeing and health of children and adolescents around the world in any setting. The solutions should have a strong impact delivering health outcomes, while being cost-efficient, scalable and sustainable.

The program will support teams and individuals who strive to:

  • go beyond research and create minimal viable healthcare products and services
  • target health Issues with a special focus on pediatrics and/or adolescents
  • enable frontline work to deliver better health outcomes
  • lower the healthcare costs and be scalable and therefore making their solution suitable for all markets including in emerging countries.

The solutions should embrace a human centric approach focusing on young people and make appropriate use of Digital Technologies (Mobile Apps, AI, Blockchain etc.)

Participants will have the opportunity to drive their project idea forward in a collaborative way engaging with the healthcare innovation ecosystem of the Basel Region. Applicants should therefore be willing to be present in the Basel region and be able to dedicate sufficient personal time to execute on their idea during the six-month period of the DayOne Acceleration Program.

The deadline for the initial application is July 31st.

An initial selection of projects will be made in early August. The selected projects will participate at the DayOne conference on September 11th in Basel where they will receive valuable feedback on their project idea from healthcare innovation experts. They will then have 3 weeks to complete a final application by September 30 th. The formal acceleration program will start no later than January 14 th 2019 and be for a period of 6 months.

Registration and more information

Get involved now, fill out the application.
For more Information, please see our FAQs.

About Fondation Botnar

Fondation Botnar is a charitable foundation established with the core purpose to support children’s basic needs throughout the world. It was founded in Basel in 2003 to continue the philanthropic work of the Botnar family. Its focus is health, nutrition and education.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Clear Solutions Labs seeks to benefit from the Basel Area

The founders of Clear Solutions Laboratories are putting together a team of experts in the fields of biotechnology, pharmaceutical science...
Read More

QuantumBasel offers access to the world’s most powerful quantum computers

QuantumBasel has consolidated its status as a neutral quantum hub with access to the world’s best quantum computers through a...
Read More

How digital transformation is driving pharmaceutical innovation in Basel

How are digital innovations such as artificial intelligence (AI) and machine learning (ML) helping to improve drug research and development?...
Read More

Medical informatics is shaping Switzerland’s digital future

Switzerland is at the forefront of embracing medical informatics, and innovative biotech hubs – such as the Basel Area –...
Read More

Ground-breaking oncology being developed in the Basel Area

The Basel Area – covering northwestern Switzerland – has seen tremendous growth in recent years, and has become a true...
Read More

Genedata expanding its user network

The Japanese biopharmaceutical firm Ajinomoto is to use the Genedata solution to accelerate its drug development processes at its site...
Read More

How Moderna is growing in Switzerland

The number one rule in real estate is “Location, Location, Location.” The global biotech company Moderna found its location in...
Read More

Sandoz decides on Basel for headquarters

Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected...
Read More

VectivBio sold for approximately 1 billion dollars

The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...
Read More

University of Basel and RocketVax present new Covid vaccine

Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...
Read More

Rami Swiss and Elbit Systems now manufacturing in Jura

The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...
Read More

Basel to become Europe’s Silicon Valley of biotech

Silicon Valley is synonymous with technology and innovation, and home to dozens of Fortune 1000 companies and thousands of startups....
Read More

Roche and Novartis among global leaders for research spending

In 2022, Roche invested 16 billion euros in research and development overall. This puts the Basel-based life sciences firm in...
Read More

Roche to found Institute for Human Biology

Roche has announced that it will be establishing the Institute of Human Biology in Basel. Up to 250 employees will...
Read More

Provectis establishes presence in Basel

Provectis Healthcare has chosen Basel as the location for its headquarters. The company is striving to become the partner of...
Read More

Alentis raises 105 million US dollars

Alentis Therapeutics has received 105 million US dollars in a series C funding round. It will invest the funds in...
Read More

Spirecut establishes presence in the Basel Area

Spirecut has opted to establish its new headquarters in the canton of Basel-Landschaft. The company is now operating out of...
Read More

Evolva launches new line for manufacturers of personal care products

Evolva, a manufacturer of active ingredients based in Reinach in the canton of Basel-Landschaft, will be presenting its new product...
Read More

Record figure for startups in the Basel Area

Basel Area Business & Innovation has supported a record number of 96 company startups in 2022. The number of settlements...
Read More

Noema Pharma raises 103 million Swiss francs from investors

Noema Pharma has raised a total of 103 million Swiss francs as part of an oversubscribed Series B financing round....
Read More

Do you have a question? We'd like to hear from you.